1. ARHGDIA, a mutant TP53‐associated Rho GDP dissociation inhibitor, is over‐expressed in gene expression profiles of TP53 disrupted chronic lymphocytic leukaemia cells. (14th February 2013) Authors: Dal Bo, Michele; Pozzo, Federico; Bomben, Riccardo; Degan, Massimo; Marconi, Daniela; Zucchetto, Antonella; Rossi, Davide; Pozzato, Gabriele; Zauli, Giorgio; Gaidano, Gianluca; Del Poeta, Giovanni; Gattei, Valter Journal: British journal of haematology Issue: Volume 161:Number 4(2013:May) Page Start: 596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease. (22nd May 2018) Authors: Raponi, Sara; Del Giudice, Ilaria; Ilari, Caterina; Cafforio, Luciana; Messina, Monica; Cappelli, Luca V.; Bonina, Silvia; Piciocchi, Alfonso; Marinelli, Marilisa; Peragine, Nadia; Mariglia, Paola; Mauro, Francesca R.; Rigolin, Gian M.; Rossi, Francesca; Bomben, Riccardo; Dal Bo, Michele; Del Poe... Journal: British journal of haematology Issue: Volume 185:Number 1(2019) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical significance of c.7544‐7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia. (20th November 2012) Authors: Del Poeta, Giovanni; Dal Bo, Michele; Del Principe, Maria Ilaria; Pozzo, Federico; Rossi, Francesca Maria; Zucchetto, Antonella; Bomben, Riccardo; Degan, Massimo; Rasi, Silvia; Rossi, Davide; Bulian, Pietro; Gaidano, Gianluca; Amadori, Sergio; Gattei, Valter Journal: British journal of haematology Issue: Volume 160:Number 3(2013:Feb.) Page Start: 415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low‐dose radiotherapy in diffuse large B‐cell lymphoma. Issue 4 (25th October 2016) Authors: Furlan, Carlo; Canzonieri, Vincenzo; Spina, Michele; Michieli, Mariagrazia; Ermacora, Anna; Maestro, Roberta; Piccinin, Sara; Bomben, Riccardo; Dal Bo, Michele; Trovo, Marco; Gattei, Valter; Tirelli, Umberto; Franchin, Giovanni; Bulian, Pietro Journal: Hematological oncology Issue: Volume 35:Issue 4(2017:Dec.) Page Start: 472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Machine Learning Application in a Phase I Clinical Trial Allows for the Identification of Clinical‐Biomolecular Markers Significantly Associated With Toxicity. Issue 3 (28th December 2021) Authors: Bedon, Luca; Cecchin, Erika; Fabbiani, Emanuele; Dal Bo, Michele; Buonadonna, Angela; Polano, Maurizio; Toffoli, Giuseppe Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 3(2022) Page Start: 686 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma. (July 2020) Authors: Dal Bo, Michele; De Mattia, Elena; Baboci, Lorena; Mezzalira, Silvia; Cecchin, Erika; Assaraf, Yehuda G.; Toffoli, Giuseppe Journal: Drug resistance updates Issue: Volume 51(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types. (12th July 2017) Authors: D'Agaro, Tiziana; Bittolo, Tamara; Bravin, Vanessa; Dal Bo, Michele; Pozzo, Federico; Bulian, Pietro; Rossi, Francesca M.; Zucchetto, Antonella; Degan, Massimo; D'Arena, Giovanni; Chiarenza, Annalisa; Zaja, Francesco; Pozzato, Gabriele; Di Raimondo, Francesco; Rossi, Davide; Gaidano, Gianluca; De... Journal: British journal of haematology Issue: Volume 182:Number 4(2018) Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Novel immunotherapeutic approaches for hepatocellular carcinoma treatment. Issue 5 (4th May 2019) Authors: Busato, Davide; Mossenta, Monica; Baboci, Lorena; Di Cintio, Federica; Toffoli, Giuseppe; Dal Bo, Michele Journal: Expert review of clinical pharmacology Issue: Volume 12:Issue 5(2019) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacological strategies to prevent SARS-CoV-2 infection and treat the early phases of COVID-19. (March 2021) Authors: Scarabel, Lucia; Guardascione, Michela; Dal Bo, Michele; Toffoli, Giuseppe Journal: International journal of infectious diseases Issue: Volume 104(2021) Page Start: 441 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target. (24th February 2020) Authors: Baboci, Lorena; Capolla, Sara; Di Cintio, Federica; Colombo, Federico; Mauro, Prisca; Dal Bo, Michele; Argenziano, Monica; Cavalli, Roberta; Toffoli, Giuseppe; Macor, Paolo Other Names: Ahmed Faheem Guest Editor. Journal: Journal of oncology Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗